Introduction: capillary glucose measurement using point-of-care glucometers is an essential part of diabetes care. We determined the technical
Introduction
The growing diabetes epidemics worldwide and in sub-Saharan Africa (SSA) poses diagnostic and management challenges [1] . Selfmeasurement and monitoring of blood glucose (SMBG) using pointof-care (POC) glucometers is an essential component of diabetic management and follow-up [2] . There is strong evidence that rigorous glycaemic control can in the long-run cost-effectively reduce the complications associated with type 2 diabetes [3] . The American Diabetes Association (ADA) recommends and promotes SMBG using glucometers in order to allow patients living with diabetes to achieve and maintain desired glycaemic targets [4] . Glucometers are very useful in timely diagnosis of acute diabetes complications, especially hypoglycaemia and hyperglycaemia which can contribute to higher morbidity and mortality [5] . Owing to the wide acceptance and use of POC glucometers in different settings, there is a competition-driven development by manufacturers in both meter and test strips technology. These innovations have allowed for greater reliability of results when compared to the reference laboratory method.
Nonetheless, there are differences in performance across these monitoring devices. These have prompted the need to develop standard performance guidelines to guide manufacturers on the minimum requirements for these glucometers [6] [7] [8] and this shall apply to at least 95% of results [6] . Many recent studies have highlighted the limitations of most glucometers in meeting these recommendations [9] [10] [11] , very few of which were carried out in SSA [12] . Because of limited resources in most SSA countries, glucometers are used beyond their intended purpose, including for diabetes diagnosis for instance. Inaccurate glucometers would therefore negatively impact on decision making and downstream consequences more in SSA than elsewhere. Furthermore, uncontrolled competition and weak or inexistent standard quality control procedures are likely to favour the marketing of sub-standards glucometers in SSA than anywhere else. Lastly, it has been shown that climate conditions can affect the performance of glucometers [10] . In the current study, we assessed the technical and clinical accuracy and precision of glucometers commonly used in Cameroon. and glucometer values; then the percentage bias was calculated as follows: (glucometer reading-reference value) × 100 ÷ reference value [13] . This was compared to the American Diabetes Association (ADA) standard of a bias of < 5% being acceptable [14, 15] . The agreement between the two measurements (that is, the glucometer and reference readings) at any given level was then examined using
Methods
Bland-Altman plots [16] . Glycaemic values were also evaluated in the and 0% in other zones. The precision of glucometers was determined by the calculation of the coefficients of variation (CV) that was further compared to the ISO criteria. The CV was computed as the standard deviation divided by the mean and expressed as a percentage [13] .
A CV of less than 5% was considered as being precise [19] . (Table 2) . For all glucometers, the correlation coefficients were always higher in men than women (all p < 0.01 for correlation coefficient comparisons; the linear regression allowed determination of the equation linking the reference blood glucose to each glucometer's blood glucose (Table 2) Pura™ yielded the highest proportion within the two ranges (Table 3) . . The lower accuracy observed in our study suggests the potential alteration of glucometers or strips by climate conditions after a long stay in SSA, as suggested earlier [10] .
Results

General characteristics of participants
Precision of glucometers ACCU-CHEK
Also, whether glucometers of lower standards are manufactured and marketed in our environment in the absence of rigorous quality control standards is unknown. Even though POC glucometers are not intended for screening and diagnosis of diabetes based on guidelines provided by the FDA, [7, 8] these devices are nonetheless used for screening and diagnosis of diabetes in SSA. All the glucometers assessed during our study overestimated the blood glucose concentration. Hence, the clinical implication of using any of these glucometers in the screening and diagnosis of diabetes is that they correctly identify patients with diabetes, but misdiagnose individuals with borderline normal or impaired fasting glucose as having impaired fasting glucose or diabetes, respectively. With regards to the use of the glucometers evaluated in our study as tools for monitoring, there might be a greater risk of iatrogenic hypoglycaemia especially with CodeFree TM , because they may result in the use of higher doses of hypoglycaemic agents. Also, the glucometers may fail to identify hypoglycaemia due to overestimation of blood glucose levels.
Regarding the statistically significant difference between women and men in the correlation between reference values and values provided by all glucometers, we speculate that they may be due to the influence of body creams and lotions used by Cameroonian women, which may contain contaminants that interact with capillary glucose measurement [26] . The following potential limitations of our study should be considered when interpreting and generalizing our findings.
Firstly, ISO recommendations were meant for self-testing. Hence, the assessment of the accuracy by a medically trained person can potentially overestimate the accuracy of the glucometers when compared to self-testing. Secondly, although all participants carefully washed their hands before capillary glucose measurement, all potential interferences to glucometer readings may not have been eliminated. Also, the investigator performing capillary glucose measurements was not blinded to the meter being used.
Nevertheless, the reference values were made available only after the completion of all glucometer-based glucose determination. Finally, measurements in the hypoglycaemic range could not be carried out;
hence, performance of the glucometers could not be assessed at all glycaemic ranges. Despite these potential limitations and unlike other studies that have been carried out on glucometers, we used very exhaustive analytical methods and endeavoured to compare the findings of our study to recommendations of more than one international body.
Conclusion
In conclusion, based on the extensive comparisons conducted in this study, no glucometer met all the required international  Failure of glucometers to comply with the norms will lead to erroneous management of diabetic patients.
What this study adds
 This study is one of the first of its kind in Cameroon that seeks to determine the accuracy and precision of four commonly used glucometers in Cameroon when compared to reference laboratory method;
 This study gives suggestions based on our results for which glucometers might be better for Cameroon.
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